학술논문

SARS-CoV-2 Testing in the Community: Testing Positive Samples with the TaqMan SARS-CoV-2 Mutation Panel To Find Variants in Real Time
Document Type
article
Author
Ashford, FionaBest, AngusDunn, Steven JAhmed, ZahraSiddiqui, HennaMelville, JordanWilkinson, SamuelMirza, JeremyCumley, NicolaStockton, JoanneFerguson, JackWheatley, LucyRatcliffe, ElizabethCasey, AnnaPlant, TimAggarwal, DineshBlane, BethBrooks, EllenaCarabelli, Alessandro MChurcher, Carol MGalai, KaterinaGirgis, Sophia TGupta, Ravi KHadjirin, Nazreen FLeek, DanielleLudden, CatherineMcManus, Georgina MPalmer, SophiePeacock, Sharon JSmith, Kim SAllara, EliasBibby, DavidBishop, ChloeBosworth, AndrewBradshaw, DanielChalker, VickiChand, MeeraDabrera, GavinEllaby, NicholasGallagher, EileenGroves, NatalieHarrison, IanHartman, HassanHopes, RichardHubb, JonathanHutchings, StephanieLackenby, AngieLedesma, JuanLee, DavidManesis, NikosManso, CarmenMbisa, TamyoMiah, ShahjahanMuir, PeterMyers, RichardOsman, HusamPatel, VineetPearson, ClarePlatt, StevenPymont, Hannah MRamsay, MaryRobinson, EstherSchaefer, UlfThornton, AliciaTwohig, Katherine AVipond, Ian BWilliams, DavidHamilton, William LWarne, BenAigrain, LouiseAlderton, AlexAmato, RobertoAriani, Cristina VBarrett, JeffBassett, Andrew RBeale, Mathew ABeaver, CharlotteBellis, Katherine LBetteridge, EmmaBonfield, JamesBronner, Iraad FChapman, Michael HSDanesh, JohnDavies, RobertDorman, Matthew JDrury, EleanorDurham, JillianFarr, Ben WFoulser, LukeGoncalves, SoniaGoodwin, ScottGourtovaia, MarinaHarrison, Ewan MJackson, David KJames, KeithJamrozy, DorotaJohnston, IanKane, LeanneKay, SallyKeatley, Jon-Paul
Source
Journal of Clinical Microbiology. 60(4)
Subject
Human Genome
Prevention
Biodefense
Genetics
Lung
Vaccine Related
Emerging Infectious Diseases
Good Health and Well Being
COVID-19
COVID-19 Testing
Humans
Mutation
SARS-CoV-2
COVID-19 Genomics UK (COG-UK) Consortium
PCR
SNPs
genome sequencing
genotyping
real time
variants of concern
Biological Sciences
Agricultural and Veterinary Sciences
Medical and Health Sciences
Microbiology
Language
Abstract
Genome sequencing is a powerful tool for identifying SARS-CoV-2 variant lineages; however, there can be limitations due to sequence dropout when used to identify specific key mutations. Recently, ThermoFisher Scientific has developed genotyping assays to help bridge the gap between testing capacity and sequencing capability to generate real-time genotyping results based on specific variants. Over a 6-week period during the months of April and May 2021, we set out to assess the ThermoFisher TaqMan mutation panel genotyping assay, initially for three mutations of concern and then for an additional two mutations of concern, against SARS-CoV-2-positive clinical samples and the corresponding COVID-19 Genomics UK Consortium (COG-UK) sequencing data. We demonstrate that genotyping is a powerful in-depth technique for identifying specific mutations, is an excellent complement to genome sequencing, and has real clinical health value potential, allowing laboratories to report and take action on variants of concern much more quickly.